Drugs
-
Leflunomide (marketed as Arava) Information
Arava (leflunomide) is indicated in adults for the treatment of active rheumatoid arthritis (RA):
- to reduce signs and symptoms
- to inhibit structural damage as evidenced by X-ray erosions and joint space narrowing
- to improve physical function.
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
-
-
-
Labeling and Regulatory History from Drugs@FDA
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-